Alten, Rieke
An, Yoorim
Kim, Dong-Hyeon http://orcid.org/0000-0003-0585-2432
Yoon, SangWook http://orcid.org/0000-0003-4690-6054
Peyrin-Biroulet, Laurent
Funding for this research was provided by:
Celltrion Healthcare
Article History
Accepted: 1 May 2022
First Online: 3 June 2022
Declarations
:
: This article was supported by Celltrion Healthcare Co., Ltd (Incheon, Republic of Korea).
: Rieke Alten has received consulting fees or honoraria, and lecture fees from Celltrion. Yoorim An, Dong-Hyeon Kim, and SangWook Yoon are employees of Celltrion Healthcare Co., Ltd. Laurent Peyrin-Biroulet reports grants received from AbbVie, Fresenius Kabi, MSD, and Takeda; consulting fees from AbbVie, Allergan, Alma, Amgen, Applied Molecular Transport, Arena, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Enterome, Enthera, Ferring, Fresenius Kabi, Galapagos, Genentech, Gilead, Hikma, Index Pharmaceuticals, Inotrem, Janssen, Lilly, MSD, Mylan, Nestlé, Norgine, Oppilan Pharma, OSE Immunotherapeutics, Pandion Therapeutics, Pfizer, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna, Sublimity Therapeutics, Takeda, Theravance, Tillotts, and Vifor; support for travel to study meetings, manuscript preparation, or other purposes from AbbVie, Amgen, Arena, Biogen, Celltrion, Ferring, Galapagos, Gilead, Hikma, Janssen, MSD, Pfizer, Pharmacosmos, Sandoz, Takeda, Tillotts, and Vifor; payment for lectures, including service on speaker bureaus, from AbbVie, Amgen, Arena, Biogen, Celltrion, Ferring, Galapagos, Gilead, Hikma, Janssen, MSD, Pfizer, Pharmacosmos, Sandoz, Takeda, Tillotts, and Vifor; and stock/stock options from CTMA.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors, including employees of the sponsor, provided intellectual contribution to manuscript development, reviewed and critically revised the manuscript, and approved the final draft.